GATS 2019: How Digitization Is Putting Trucking in the Fast Lane

While the ways people shop and trade have changed markedly through digitization, the way products move from seller to buyer largely has not.

This may be changing soon though, based on the developments of the transportation industry.

The Great American Trucking Show concluded in Dallas this week, and the event hosted more than just the latest engines and wheels.

“The trucking industry has become much more sophisticated in knowing what various technologies they can incorporate to their operation to become much more streamlined, more efficient, handle more comprehensive, sophisticated operations,” Paul Till, Sales Manager at PCS Software said. “So, the need for advanced technology is really on the forefront of the minds now in the industry.”

With more deliveries on the road than any time in history, it is critical that transportation companies create efficient routes and systems to stay ahead of the competition. However, in an industry that is undergoing rapid change for the first time in generations, they must invest in themselves with one eye on the future.

“Technology is a tool. I think the challenge for most transportation companies is finding that right tool that fits their operation. And it’s just not about what the needs of today are, its about being forward moving,” Till said.

The possibility of autonomously-driven trucks could revolutionize human roles in the industry and lead to a further need for technological savvy in the world of trucking. Progress in this area is only increasing, and the decisions trucking companies make could change the industry for the foreseeable future. These changes will not only impact truck drivers and logistics professionals but consumers and sellers as well.

Technology is a Tool

 

The Outlook of the Industry

 

Streamlining Operations

 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More